🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Sagility Limited SAGILITY NIFTY_SMALLNSEPHARMA

Healthcare · Health Information Services · India
https://www.sagilityhealth.com
Company Profile ↓
₹42.00
-5.90% 1Y
Mkt Cap₹19,661.58 Cr
P/E35.90
P/B2.00
Div. Yield0.47%
52W High₹54.53
52W Low₹36.35
Book Value₹20.63
EPS (TTM)₹1.17

Company Overview

Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrative support provider, and data management services. It also provides utilization and care management, and population health management, as well as revenue cycle management functions, such as financial clearance, medical coding, billing, labs and durable medical equipment support, patient access and engagement, and accounts receivable follow-up services. In addition, it provides services to pharmacy benefit managers that manage prescription drugs for members under health insurance plans. Further, it offers various platforms, including document processing engine, genAI solutions for customer and member engagement, nurse assist, revenue cycle management, provider forward, enrolment and plan automation, and contract central. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. The company was incorporated in 2021 and is based in Bengaluru, India. Sagility Limited operates as a subsidiary of Sagility B.V.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 86.1% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 19.5% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 35.9, below the sector median of 40.0.

Healthy Margins

Operating margin of 17.7% supports profitability.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.12.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹7,192.85 Cr (+29.1% YoY); net profit ₹924.77 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +29.1%, earnings +71.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 19.5%, profit CAGR 86.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:19.47%
1 Year:29.14%

Compounded Profit Growth

5 Years:86.06%
1 Year:71.53%

Stock Price Performance

1 Year:-5.90%
6 Months:-17.00%
3 Months:-2.17%
1 Month:+5.11%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 31% of range
₹36.35 ₹54.53
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)57.64 · Neutral
Price Performance
1M+5.11%
3M-2.17%
6M-17.00%
1Y-5.90%
Valuation vs Sector

P/E of 35.90 is below the sector median of 39.97 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 19.5% over 5 years.
  • Profit CAGR of 86.1% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
35.90
Industry PE
39.97
Forward P/E
14.16
PEG Ratio
-
Book Value
₹20.63
Price to Book
2.00
P/S
2.74
EV/EBITDA
11.11
Dividend Yield
0.47%

Growth (CAGR)

Revenue 5Y
19.47%
Profit 5Y
86.06%
Revenue (YoY)
29.14%
Earnings (YoY)
71.53%

Profitability & Returns

ROCE
12.50%
ROE
9.57%
ROA
7.34%
Profit Margin
12.86%
Op Margin
17.70%
Gross Margin
37.30%
EPS (Latest Qtr)
₹0.56
EPS (TTM)
₹1.17

Balance Sheet & Liquidity

Debt/Equity
0.12
Quick Ratio
1.45
Current Ratio
1.55
Debt
₹1,110.54 Cr
Total Assets
₹12,601.08 Cr
Current Assets
₹2,944.54 Cr
Working Capital
₹1,047.04 Cr

Ownership

Promoter Holding
50.95%
Chg in Prom Hold
-0.00%
FII / Inst Holding
20.60%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
₹19,661.58 Cr
Total Revenue (TTM)
₹7,192.85 Cr
EBITDA
₹1,825.43 Cr
Free Cash Flow
₹1,010.76 Cr
Operating Cash Flow
₹1,202.97 Cr
Shares Outstanding
₹468.13 Cr
Gross Margin
37.30%
Payout Ratio
2.53%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SAGILITY Sagility Limited NIFTY_SMALLNSEPHARMA 42.00 35.90 ₹19,661.58 Cr 0.47% 12.50% 9.57% 19.47% 86.06%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 1,116.00 Cr1,094.00 Cr1,260.00 Cr1,283.00 Cr1,223.00 Cr1,325.00 Cr1,453.07 Cr1,568.48 Cr1,538.94 Cr1,658.00 Cr1,971.15 Cr2,024.26 Cr
Cost of Revenue ------862.00 Cr974.10 Cr987.21 Cr-1,219.16 Cr1,276.89 Cr
Gross Profit ------591.07 Cr594.38 Cr551.73 Cr-752.00 Cr747.37 Cr
Operating Expenses 852.00 Cr860.00 Cr1,000.00 Cr976.00 Cr1,029.00 Cr1,024.00 Cr315.01 Cr335.69 Cr323.83 Cr1,243.00 Cr364.40 Cr386.86 Cr
Operating Income 98.00 Cr63.00 Cr84.00 Cr131.00 Cr84.00 Cr175.00 Cr276.05 Cr258.69 Cr227.90 Cr293.00 Cr387.59 Cr360.50 Cr
EBITDA 264.00 Cr234.00 Cr260.00 Cr307.00 Cr194.00 Cr301.00 Cr436.18 Cr383.16 Cr355.98 Cr415.00 Cr486.70 Cr509.44 Cr
Interest Expense 47.00 Cr48.00 Cr47.00 Cr43.00 Cr37.00 Cr30.00 Cr30.19 Cr29.83 Cr27.41 Cr25.00 Cr24.66 Cr22.10 Cr
Pretax Income 62.00 Cr43.00 Cr44.00 Cr93.00 Cr71.00 Cr160.00 Cr289.81 Cr238.99 Cr210.39 Cr327.00 Cr338.52 Cr363.18 Cr
Tax Provision 19.22 Cr8.17 Cr-27.28 Cr13.02 Cr48.99 Cr43.20 Cr72.90 Cr56.41 Cr61.83 Cr75.21 Cr70.86 Cr105.46 Cr
Net Income 42.00 Cr35.00 Cr71.00 Cr80.00 Cr22.00 Cr117.00 Cr216.91 Cr182.57 Cr148.56 Cr251.00 Cr267.66 Cr257.73 Cr
Diluted EPS 0.220.180.370.190.050.250.460.390.320.540.570.56

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 923.00 Cr4,218.41 Cr4,753.56 Cr5,569.92 Cr7,192.85 Cr
Cost of Revenue -2,503.01 Cr2,747.00 Cr3,498.90 Cr4,510.28 Cr
Gross Profit -1,715.40 Cr2,006.55 Cr2,071.02 Cr2,682.57 Cr
Operating Expenses 730.00 Cr1,320.35 Cr1,607.67 Cr1,239.99 Cr1,409.67 Cr
Operating Income 46.00 Cr395.05 Cr398.88 Cr831.03 Cr1,272.90 Cr
EBITDA 193.00 Cr1,044.86 Cr1,116.04 Cr1,354.19 Cr1,825.43 Cr
Interest Expense 65.00 Cr214.85 Cr185.15 Cr127.10 Cr99.16 Cr
Pretax Income -2.00 Cr185.68 Cr241.68 Cr760.23 Cr1,238.90 Cr
Tax Provision -3.04 Cr42.10 Cr13.41 Cr221.11 Cr314.13 Cr
Net Income -5.00 Cr143.57 Cr228.27 Cr539.12 Cr924.77 Cr
Diluted EPS -0.020.310.491.17-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -10,590.48 Cr10,664.20 Cr11,050.66 Cr12,601.08 Cr
Current Assets -1,793.42 Cr1,719.92 Cr1,820.77 Cr2,944.54 Cr
Cash & Equivalents -585.29 Cr344.13 Cr343.76 Cr357.92 Cr
Inventory -----
Receivables -637.64 Cr742.16 Cr865.82 Cr1,839.03 Cr
Total Liabilities -4,383.81 Cr4,221.07 Cr2,714.61 Cr2,941.98 Cr
Current Liabilities -1,056.44 Cr1,452.12 Cr1,089.10 Cr1,897.50 Cr
Long Term Debt -2,323.70 Cr1,664.70 Cr567.04 Cr0
Total Debt -2,871.60 Cr2,531.71 Cr1,401.94 Cr1,110.54 Cr
Total Equity -6,206.67 Cr6,443.13 Cr8,336.05 Cr9,659.10 Cr
Shares Outstanding -468.13 Cr468.13 Cr468.13 Cr468.13 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -32.00 Cr856.78 Cr973.25 Cr1,214.07 Cr1,202.97 Cr
Investing Cash Flow -7,711.00 Cr-129.06 Cr-469.06 Cr-964.21 Cr-710.69 Cr
Financing Cash Flow 8,116.00 Cr-544.62 Cr-751.34 Cr-256.07 Cr-501.40 Cr
Capital Expenditure -7.00 Cr-143.68 Cr-182.73 Cr-124.44 Cr-192.21 Cr
Free Cash Flow -39.00 Cr713.10 Cr790.53 Cr1,089.63 Cr1,010.76 Cr
Net Change in Cash 374.00 Cr183.10 Cr-247.14 Cr-6.21 Cr-9.12 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -40.7%42.2%37.2%37.3%
Operating Margin % 5.0%9.4%8.4%14.9%17.7%
Net Margin % -0.5%3.4%4.8%9.7%12.9%
ROE % -2.3%3.5%6.5%9.6%
ROCE % -4.1%4.3%8.3%11.9%

Shareholding Pattern

Insiders
50.95%
Institutions
20.60%
Public Float
42.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SAGILITY

Google News Fri, 15 May 2026

Sagility Limited (NSE:SAGILITY) Just Released Its Yearly Earnings: Here's What Analysts Think - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNNG45ZWhOVWV0R2J1WVlxWS1jbTdmeVJ2aEtGa1pFb0JyamtIQV8zMUhJWDNDTmdYY1JxSFkzUDVzYm94SXdHY2pSc3JmcFZDaC1GNF92dEZJUVJZRklTang4d19vZFQ0LUhrVDFXcjM2Zk5JZ3ZuNXNiVVBWS1ZaR1ZRSFZUdUFleTdRSU…

Google News Wed, 24 Jun 2026

Sagility India Share Latest News 🔴sagility India Share Today Update, Market And Fundamental Analysis Aegean Airlines Dubai Flight Suspension (RlS0RO1Krn) - Fathom Journal

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE41VHVicXdaT1ZTbXR2MDltT2o5NHQzT05LMmFkWWRyRXMwM2Fma3IwdmxXMDc5eXU2T01UeVlqbzRwQnhUbUVHVFpkSTR2ZFdCZE1mVGw5ajg5TldyQVpUajJtd3M?oc=5" target="_blank">Sagility India Share Latest News…

Google News Mon, 13 Jul 2026

Sagility to host Q1 FY27 earnings webinar on July 21 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOU1Z6OW1ic2NZMDZOeTdOQlVINUdWTnhjVWZCYVhuQW5VV084bkJwSXFFTkVnWlFxRFNFX0Rab0M5dU9zenczTkVYaTB4VkpBZWxSYmxpazB0QjVXOURvT2tFTFBZNnFJYkxUbENhMHFpSXRCT01iRlF5eElUbFI2eUZWWU01WnJ3THZuND…

Google News Mon, 22 Jun 2026

Sagility Ltd Share Price Target, Forecast for Long Term Equity. - HDFC Sky

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQdVJsbUR1OU5zQldsaTAxRnhYRmhDOUdIMTNienZUb0lNVW5XaW1sdWw1eVJkT3oyV1FWVkZNT1ZsajFmUEtUOG4tVUVvbEZ1QmFwTWV4R1VUOHlxX2R3VjQzdzNLX2ZmX0dsWmg0ajhIUWhoV2taM3lfTk5WUFdlZy1LZw?oc=5" targe…

Google News Wed, 25 Mar 2026

Sagility shares rocket 8% after Nomura initiates coverage with buy rating, sees it as top AI beneficiary - The Economic Times

<a href="https://news.google.com/rss/articles/CBMigAJBVV95cUxOWVFkS1gxbV83TUF5WnlxMG1xX2ZTdXc0Q1ByamZCQkdfMG5zVkl0X21DeXQtdEFOd2hKLXdobUtXUWdUMXRNLXYxWVBucks1THpDSHk5VEY3cHJ3N0UyemRlQndSbXVOUGxBdlNlZElGLXdQdGdNbnN1Z0pOakRtc3l6S0Nac1I3Tk12X3…

Google News Mon, 20 Apr 2026

Elara initiates on Sagility with Buy; sees long growth runway, 26% upside - Business Standard

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxNblZzZXVuMWF3RmVrZXJ4VFk5UHlMWG9FMGkyRmU5T1R6UTlJckhVdGlNWERmZGFpLTcwT3pWYjEyTzVza09jazY3U1VxTjhiT2pncHZVOWdJeVVpME9SaGljZ1BkUE9uWjNqd3U2eTJ5MHBxX2JHNU1WZjdVdmdoYU5aaHFqOFZpQ1B5cV…

SAGILITY — Frequently Asked Questions

What is the current share price of Sagility Limited (SAGILITY)?

As of 2026-07-15 09:52 IST, Sagility Limited (SAGILITY) trades at ₹42.00 on NSE. Its 52-week range is ₹36.35 to ₹54.53.

What is the market capitalisation of SAGILITY?

Sagility Limited (SAGILITY) has a market capitalisation of ₹19,661.58 Cr on NSE.

What is the P/E ratio of SAGILITY?

SAGILITY trades at a trailing price-to-earnings (P/E) ratio of 35.90. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 2.00.

Does SAGILITY pay a dividend?

Sagility Limited (SAGILITY) currently offers a dividend yield of 0.47%.

What is the return on equity (ROE) of SAGILITY?

SAGILITY has a return on equity (ROE) of 9.57%. Its return on capital employed (ROCE) is 12.50%.

Is SAGILITY a good stock to buy?

This page provides a data-driven analysis of Sagility Limited (SAGILITY), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space